Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational analysis of the estrogen receptor-alpha gene in familial ovarian cancer.
Wu HJ, Sekine M, Kashima K, Hirai Y, Hatae M, Kobayashi I, Obata K, Enomoto T, Umesaki N, Ushijima K, Tanaka K; Japanese Familial Ovarian Cancer Study Group. Wu HJ, et al. Among authors: umesaki n. J Obstet Gynaecol Res. 2005 Oct;31(5):375-83. doi: 10.1111/j.1447-0756.2005.00305.x. J Obstet Gynaecol Res. 2005. PMID: 16176503
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
Amikura T, Sekine M, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Nishino K, Haino K, Tanaka K; Japanese Familial Ovarian Cancer Study Group. Amikura T, et al. Among authors: umesaki n. Gynecol Oncol. 2006 Feb;100(2):365-71. doi: 10.1016/j.ygyno.2005.09.010. Epub 2005 Dec 9. Gynecol Oncol. 2006. PMID: 16337994
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.
Nagase S, Inoue Y, Umesaki N, Aoki D, Ueda M, Sakamoto H, Kobayashi S, Kitagawa R, Toita T, Nagao S, Hasegawa K, Fukasawa I, Fujiwara K, Watanabe Y, Ito K, Niikura H, Iwasaka T, Ochiai K, Katabuchi H, Kamura T, Konishi I, Sakuragi N, Tanaka T, Hirai Y, Hiramatsu Y, Mukai M, Yoshikawa H, Takano T, Yoshinaga K, Otsuki T, Sakuma M, Inaba N, Udagawa Y, Yaegashi N; Japan Society of Gynecologic Oncology. Nagase S, et al. Among authors: umesaki n. Int J Clin Oncol. 2010 Apr;15(2):117-24. doi: 10.1007/s10147-010-0061-x. Epub 2010 Mar 24. Int J Clin Oncol. 2010. PMID: 20333431
Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.
Sugiyama T, Yakushiji M, Kamura T, Ikeda M, Umesaki N, Hasegawa K, Ishikawa M, Saji F, Hiura M, Takahashi T, Sato S, Ochiai K, Kikkawa F, Takeuchi S, Ohashi Y, Noda K; Japan CPT-11 Study Group. Sugiyama T, et al. Among authors: umesaki n. Oncology. 2002;63(1):16-22. doi: 10.1159/000065715. Oncology. 2002. PMID: 12187066 Clinical Trial.
190 results